# EDGAR Filing Document

**Accession Number:** 0000078003
**File Stem:** 0000078003-23-000060
**Filing Date:** 2023-3
**Character Count:** 10847
**Document Hash:** 3eb0ec99de6e1e756ec87da680a6d6ef
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000078003-23-000060.hdr.sgml**: 20230330

**ACCESSION NUMBER**: 0000078003-23-000060

**CONFORMED SUBMISSION TYPE**: SC 13G

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20230330

**DATE AS OF CHANGE**: 20230330

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Zura Bio Ltd
- **CENTRAL INDEX KEY:** 0001855644
- **STANDARD INDUSTRIAL CLASSIFICATION:** BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** E9
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SC 13G
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-92696
- **FILM NUMBER:** 23781568

**BUSINESS ADDRESS:**
- **STREET 1:** 4225 EXECUTIVE SQUARE
- **STREET 2:** SUITE 600
- **CITY:** LA JOLLA
- **STATE:** CA
- **ZIP:** 92037
- **BUSINESS PHONE:** 858-247-0520

**MAIL ADDRESS:**
- **STREET 1:** 4225 EXECUTIVE SQUARE
- **STREET 2:** SUITE 600
- **CITY:** LA JOLLA
- **STATE:** CA
- **ZIP:** 92037

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** JATT Acquisition Corp
- **DATE OF NAME CHANGE:** 20210407
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** PFIZER INC
- **CENTRAL INDEX KEY:** 0000078003
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **IRS NUMBER:** 135315170
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SC 13G

**BUSINESS ADDRESS:**
- **STREET 1:** 66 HUDSON BOULEVARD EAST
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10001-2192
- **BUSINESS PHONE:** 2127332323

**MAIL ADDRESS:**
- **STREET 1:** 66 HUDSON BOULEVARD EAST
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10001-2192

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** PFIZER CHARLES & CO INC
- **DATE OF NAME CHANGE:** 19710908

CUSIP No. G9TY5A101

---

| |
|:---|
| SECURITIES AND EXCHANGE COMMISSION |
| Washington, D.C. 20549 |
| SCHEDULE 13G |
| (Rule 13d-102) |
| INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT |
| TO RULES 13d-1(b),(c) AND (d) AND AMENDMENTS THERETO FILED |
| PURSUANT TO RULE 13d-2(b) |
| (Amendment No.) <sup>1</sup> |
| Zura Bio Limited |
| (Name of Issuer) |
| Class A Ordinary Shares, $0.0001 par value |
| (Title of Class of Securities) |
| G9TY5A101 |
| (CUSIP Number) |
| March 20, 2023 |
| (Date of Event Which Requires Filing of this Statement) |

---

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

[ ] Rule 13d-1(b)

[ ] Rule 13d-1(c)

[X] Rule 13d-1(d)&nbsp;&nbsp;&nbsp;&nbsp;

<br>__________

1 The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act.

Page 1 of 6

------

CUSIP No. G9TY5A101

---

| | | | | |
|:---|:---|:---|:---|:---|
| 1. | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;NAME OF REPORTING PERSON<br>S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (VOLUNTARY)<br>Pfizer Inc. | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;NAME OF REPORTING PERSON<br>S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (VOLUNTARY)<br>Pfizer Inc. | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;NAME OF REPORTING PERSON<br>S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (VOLUNTARY)<br>Pfizer Inc. | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;NAME OF REPORTING PERSON<br>S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (VOLUNTARY)<br>Pfizer Inc. |
| 2. | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP | (a) [ ]<br>(b) [ ] |
| 3. | SEC USE ONLY | SEC USE ONLY | SEC USE ONLY | SEC USE ONLY |
| 4. | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;CITIZENSHIP OR PLACE OF ORGANIZATION<br>Delaware | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;CITIZENSHIP OR PLACE OF ORGANIZATION<br>Delaware | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;CITIZENSHIP OR PLACE OF ORGANIZATION<br>Delaware | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;CITIZENSHIP OR PLACE OF ORGANIZATION<br>Delaware |
| NUMBER OF <br>SHARES <br>BENEFICIALLY <br>OWNED BY <br>EACH <br>REPORTING <br>PERSON <br>WITH | NUMBER OF <br>SHARES <br>BENEFICIALLY <br>OWNED BY <br>EACH <br>REPORTING <br>PERSON <br>WITH | 5. | SOLE VOTING POWER 2,970,022 Class A Ordinary Shares, $0.0001 par value | SOLE VOTING POWER 2,970,022 Class A Ordinary Shares, $0.0001 par value |
| NUMBER OF <br>SHARES <br>BENEFICIALLY <br>OWNED BY <br>EACH <br>REPORTING <br>PERSON <br>WITH | NUMBER OF <br>SHARES <br>BENEFICIALLY <br>OWNED BY <br>EACH <br>REPORTING <br>PERSON <br>WITH | 6. | SHARED VOTING POWER -0- | SHARED VOTING POWER -0- |
| NUMBER OF <br>SHARES <br>BENEFICIALLY <br>OWNED BY <br>EACH <br>REPORTING <br>PERSON <br>WITH | NUMBER OF <br>SHARES <br>BENEFICIALLY <br>OWNED BY <br>EACH <br>REPORTING <br>PERSON <br>WITH | 7. | SOLE DISPOSITIVE POWER 2,970,022 Class A Ordinary Shares, $0.0001 par value | SOLE DISPOSITIVE POWER 2,970,022 Class A Ordinary Shares, $0.0001 par value |
| NUMBER OF <br>SHARES <br>BENEFICIALLY <br>OWNED BY <br>EACH <br>REPORTING <br>PERSON <br>WITH | NUMBER OF <br>SHARES <br>BENEFICIALLY <br>OWNED BY <br>EACH <br>REPORTING <br>PERSON <br>WITH | 8. | SHARED DISPOSITIVE POWER -0- | SHARED DISPOSITIVE POWER -0- |
| 9. | AGGREGATE AMOUNT BENEFICIALLY OWNED <br>BY EACH REPORTING PERSON 2,970,022\* | AGGREGATE AMOUNT BENEFICIALLY OWNED <br>BY EACH REPORTING PERSON 2,970,022\* | AGGREGATE AMOUNT BENEFICIALLY OWNED <br>BY EACH REPORTING PERSON 2,970,022\* | AGGREGATE AMOUNT BENEFICIALLY OWNED <br>BY EACH REPORTING PERSON 2,970,022\* |
| 10. | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES | <br> [ ] |
| 11. | &nbsp;&nbsp;PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 10.78%\* | &nbsp;&nbsp;PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 10.78%\* | &nbsp;&nbsp;PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 10.78%\* | &nbsp;&nbsp;PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 10.78%\* |
| 12. | &nbsp;&nbsp;TYPE OF REPORTING PERSON CO | &nbsp;&nbsp;TYPE OF REPORTING PERSON CO | &nbsp;&nbsp;TYPE OF REPORTING PERSON CO | &nbsp;&nbsp;TYPE OF REPORTING PERSON CO |

---

\* Based on 27,552,148 Class A Ordinary Shares, $0.0001 par value per share, of the Issuer as set forth in the Issuer's Current Report on Form 8-K dated March 20, 2023, and filed with the SEC on March 24, 2023.

Page 2 of 6

------

CUSIP No. G9TY5A101

<u>SCHEDULE 13G</u>

---

| | |
|:---|:---|
| ITEM 1(a) | NAME OF ISSUER: Zura Bio Limited (the "Issuer"). |
| ITEM 1(b) | ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES: |
|  | 4225 Executive Square, Suite 600, La Jolla, CA 92037 |
| ITEM 2(a) | NAME OF PERSON FILING: |
|  | Pfizer Inc. ("Pfizer") |
| ITEM 2(b) | ADDRESS OF PRINCIPAL BUSINESS OFFICE: |
|  | 66 Hudson Boulevard East, New York, NY 10001 |
| ITEM 2(c) | CITIZENSHIP: |
|  | Delaware |
| ITEM 2(d) | TITLE OF CLASS OF SECURITIES: |
|  | Class A Ordinary Shares, $0.0001 par value |
| ITEM 2(e) | CUSIP NUMBER: G9TY5A101 |
| ITEM 3 | IF THIS STATEMENT IS FILED PURSUANT TO §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: |
|  | Not applicable. |

---

(a) Broker or dealer registered under section 15 of the Act (15 U.S.C. 78os). <br>(b) Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c). <br>(c) Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c). <br>(d) Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8). <br>(e) An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E). <br>(f) An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F). <br>(g) A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G).

Page 3 of 6

------

CUSIP No. G9TY5A101

<br>(h) A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813). <br>(i) A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3). <br>(j) A non-US institution, in accordance with §240.13d-1(b)(1)(ii)(J); <br>(k) Group, in accordance with §230.405 240.13d-1(b)(1)(ii)(K). <br>If filing as a non-US institution in accordance with §240.13d-1(b)(1)(ii)(J), please specify the type of institution: Not applicable.

Page 4 of 6

------

CUSIP No. G9TY5A101

---

| | | |
|:---|:---|:---|
| ITEM 4 | OWNERSHIP: | OWNERSHIP: |
| | The information requested in this item is incorporated herein by reference to rows 5 through 11 of the cover page to this Schedule 13G. | The information requested in this item is incorporated herein by reference to rows 5 through 11 of the cover page to this Schedule 13G. |
| ITEM 5 | OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS: | OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS: |
| | Not applicable. | Not applicable. |
| ITEM 6 | OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON: | OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON: |
| | Not applicable. | Not applicable. |
| ITEM 7 | IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT COMPANY: | IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT COMPANY: |
| | Not applicable. | Not applicable. |
| ITEM 8 | | IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP: |
| | | Not applicable. |
| ITEM 9 | ITEM 9 | NOTICE OF DISSOLUTION OF GROUP: |
| | | Not applicable. |
| ITEM 10 | ITEM 10 | CERTIFICATION: |
| | | Not applicable. |

---

Page 5 of 6

------

CUSIP No. G9TY5A101

SIGNATURE

After reasonable inquiry and to the best of their knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete and correct.

Dated: March 30, 2023

---

| | |
|:---|:---|
| PFIZER INC. | PFIZER INC. |
| By: | /s/ Susan Grant |
| Name: | Susan Grant |
| Title: | Assistant Secretary |

---

Page 6 of 6